ATE399021T1 - Kombinationszusammensetzungen für die lyme- erkrankung und anwendungen - Google Patents
Kombinationszusammensetzungen für die lyme- erkrankung und anwendungenInfo
- Publication number
- ATE399021T1 ATE399021T1 AT98908885T AT98908885T ATE399021T1 AT E399021 T1 ATE399021 T1 AT E399021T1 AT 98908885 T AT98908885 T AT 98908885T AT 98908885 T AT98908885 T AT 98908885T AT E399021 T1 ATE399021 T1 AT E399021T1
- Authority
- AT
- Austria
- Prior art keywords
- antigen
- compositions
- pathogen
- borrelia burgdorferi
- lyme disease
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 208000016604 Lyme disease Diseases 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 abstract 4
- 102000036639 antigens Human genes 0.000 abstract 4
- 108091007433 antigens Proteins 0.000 abstract 4
- 241000589969 Borreliella burgdorferi Species 0.000 abstract 3
- 244000052769 pathogen Species 0.000 abstract 3
- 230000001717 pathogenic effect Effects 0.000 abstract 3
- 241000124008 Mammalia Species 0.000 abstract 2
- 241000282465 Canis Species 0.000 abstract 1
- 241000282472 Canis lupus familiaris Species 0.000 abstract 1
- 241000711573 Coronaviridae Species 0.000 abstract 1
- 208000000655 Distemper Diseases 0.000 abstract 1
- 241000283086 Equidae Species 0.000 abstract 1
- 241000283073 Equus caballus Species 0.000 abstract 1
- 241000282324 Felis Species 0.000 abstract 1
- 108700006640 OspA Proteins 0.000 abstract 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 abstract 1
- 241000125945 Protoparvovirus Species 0.000 abstract 1
- 206010037742 Rabies Diseases 0.000 abstract 1
- 208000014058 canine distemper Diseases 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 241000701161 unidentified adenovirus Species 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/828—Bacterial vaccine for canidae or mustelidae, e.g. dogs, foxes, minks
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/829—Bacterial vaccine for equine species, e.g. horses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/788—Of specified organic or carbon-based composition
- Y10S977/802—Virus-based particle
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/918—Immunological
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Dental Preparations (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/812,348 US6368603B1 (en) | 1997-03-05 | 1997-03-05 | Lyme combination compositions and uses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE399021T1 true ATE399021T1 (de) | 2008-07-15 |
Family
ID=25209312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98908885T ATE399021T1 (de) | 1997-03-05 | 1998-03-04 | Kombinationszusammensetzungen für die lyme- erkrankung und anwendungen |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6368603B1 (de) |
| EP (1) | EP0988051B1 (de) |
| JP (1) | JP4301415B2 (de) |
| CN (1) | CN1252730A (de) |
| AT (1) | ATE399021T1 (de) |
| AU (1) | AU746185B2 (de) |
| BR (1) | BR9808821A (de) |
| CA (1) | CA2283420C (de) |
| DE (1) | DE69839640D1 (de) |
| DK (1) | DK0988051T3 (de) |
| ES (1) | ES2310004T3 (de) |
| HU (1) | HU228709B1 (de) |
| IL (2) | IL131678A0 (de) |
| PL (1) | PL190989B1 (de) |
| PT (1) | PT988051E (de) |
| WO (1) | WO1998039028A1 (de) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA964896B (en) * | 1995-06-07 | 1997-01-08 | Connaught Lab | Expression of lipoproteins |
| AU758764B2 (en) * | 1998-03-02 | 2003-03-27 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Epitope peptides immunogenic against (streptococcus pneumoniae) |
| AU5622800A (en) * | 1999-06-18 | 2001-01-09 | Med Immune, Inc. | Combined decorin binding protein and outer surface protein compositions and methods of use |
| DE10162434A1 (de) * | 2001-12-18 | 2003-09-25 | November Ag Molekulare Medizin | Expressionsvektor und Verfahren zur Herstellung eines Expressionsvektors |
| US7906311B2 (en) | 2002-03-20 | 2011-03-15 | Merial Limited | Cotton rat lung cells for virus culture |
| US20040197339A1 (en) * | 2003-01-29 | 2004-10-07 | Brown Paul R. | Vaccine for Lyme disease |
| EP1606419A1 (de) | 2003-03-18 | 2005-12-21 | Quantum Genetics Ireland Limited | Systeme und methoden zur erhohung der milchproduktion in tieren |
| US7468273B2 (en) | 2003-05-01 | 2008-12-23 | Meial Limited | Canine GHRH gene, polypeptides and methods of use |
| ES2417019T3 (es) | 2003-11-13 | 2013-08-05 | University Of Georgia Research Foundation, Inc. | Procedimiento de caracterización del virus de la enfermedad de la bursitis infecciosa |
| CA2556911C (en) | 2004-02-19 | 2013-07-30 | The Governors Of The University Of Alberta | Leptin promoter polymorphisms and uses thereof |
| PL1881845T3 (pl) | 2005-04-25 | 2010-08-31 | Merial Ltd | Szczepionki przeciwko wirusowi Nipah |
| US20080241184A1 (en) | 2005-08-25 | 2008-10-02 | Jules Maarten Minke | Canine influenza vaccines |
| EP2186823A1 (de) | 2005-11-14 | 2010-05-19 | Merial Limited | Gentherapie für Nierenversagen |
| US7771995B2 (en) | 2005-11-14 | 2010-08-10 | Merial Limited | Plasmid encoding human BMP-7 |
| US7682619B2 (en) * | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
| US7862821B2 (en) | 2006-06-01 | 2011-01-04 | Merial Limited | Recombinant vaccine against bluetongue virus |
| UA99719C2 (ru) | 2006-11-03 | 2012-09-25 | Шеринг-Плау Лтд. | Вакцина для собак против болезни лайма |
| UA100692C2 (ru) | 2007-05-02 | 2013-01-25 | Мериал Лимитед | Днк-плазмиды, имеющие повышенную экспрессию и стабильность |
| CA2757030C (en) | 2009-04-03 | 2019-01-15 | Merial Limited | Vectors comprising newcastle disease viruses and compositions thereof |
| RU2636455C2 (ru) | 2010-05-14 | 2017-11-23 | Баксалта Инкорпорейтид, (US) | Химерные гены ospa, белки и способы их применения |
| WO2012030720A1 (en) | 2010-08-31 | 2012-03-08 | Merial Limited | Newcastle disease virus vectored herpesvirus vaccines |
| WO2012090073A2 (en) | 2010-12-30 | 2012-07-05 | The Netherlands Cancer Institute | Methods and compositions for predicting chemotherapy sensitivity |
| US20140296248A1 (en) | 2011-04-04 | 2014-10-02 | Stichting het Nederlands Kanker Instiuut-Antoni van Leeuwenhoek ziekenhuis | Methods and compositions for predicting resistance to anticancer treatment |
| EP2694678A2 (de) | 2011-04-04 | 2014-02-12 | Netherland Cancer Institute | Verfahren und zusammensetzungen zur vorhersage der resistenz gegenüber einer antikrebsbehandlung |
| WO2012145577A1 (en) | 2011-04-20 | 2012-10-26 | Merial Limited | Adjuvanted rabies vaccine with improved viscosity profile |
| KR102007444B1 (ko) | 2011-04-25 | 2019-08-06 | 어드밴스드 바이오사이언스 라보라토리즈, 인코포레이티드 | 절단형 hiv 피막 단백질(env), 이와 관련된 방법 및 조성물 |
| EP2714077B1 (de) | 2011-06-01 | 2018-02-28 | Merial, Inc. | Nadellose verabreichung von prrsv-impfstoffen |
| JP6041361B2 (ja) | 2011-08-12 | 2016-12-07 | メリアル インコーポレイテッド | 生物学的製品、特にはワクチンの真空保存 |
| WO2013093629A2 (en) | 2011-12-20 | 2013-06-27 | Netherlands Cancer Institute | Modular vaccines, methods and compositions related thereto |
| WO2013138776A1 (en) | 2012-03-16 | 2013-09-19 | Merial Limited | Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g |
| US9556419B2 (en) | 2013-03-12 | 2017-01-31 | Merial Inc. | Reverse genetics Schmallenberg virus vaccine compositions, and methods of use thereof |
| EP3215188A1 (de) | 2014-11-03 | 2017-09-13 | Merial, Inc. | Verfahren zur verwendung von mikronadelimpfstoffformulierungen zur anregung von schützender immunität gegen das tollwutvirus bei tieren |
| PL3313864T3 (pl) | 2015-06-23 | 2022-01-03 | Boehringer Ingelheim Animal Health USA Inc. | Rekombinowane wektory wirusowe zawierające drugorzędne białko prrsv oraz sposoby ich wytwarzania i zastosowania |
| MX2018012477A (es) | 2016-04-14 | 2019-03-07 | Merial Inc | Composiciones de multiples dosis que contienen un conservador de poliamida antimicrobiana u octenidina. |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK590288D0 (da) * | 1988-10-24 | 1988-10-24 | Symbicom Ab | Kemiske forbindelser |
| US5266313A (en) | 1987-02-03 | 1993-11-30 | The United States Of America As Represented By The Department Of Health And Human Services | Raccoon poxvirus as a gene expression and vaccine vector for genes of rabies virus and other organisms |
| EP0465204B1 (de) * | 1990-07-06 | 2000-09-20 | American Home Products Corporation | Impfstoff gegen die Lyme-Krankheit |
| US5843456A (en) * | 1991-03-07 | 1998-12-01 | Virogenetics Corporation | Alvac poxvirus-rabies compositions and combination compositions and uses |
| AU2917892A (en) | 1991-11-12 | 1993-06-15 | Regents Of The University Of Minnesota | Recombinant vaccine against lyme disease |
| US5656451A (en) * | 1993-07-30 | 1997-08-12 | Yale University | OspE, OspF, and S1 polypeptides in borrelia burgdorferi |
| US5728385A (en) * | 1993-08-12 | 1998-03-17 | Classen Immunotherapies, Inc. | Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae |
| FR2751227B1 (fr) * | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives |
-
1997
- 1997-03-05 US US08/812,348 patent/US6368603B1/en not_active Expired - Lifetime
-
1998
- 1998-03-04 EP EP98908885A patent/EP0988051B1/de not_active Expired - Lifetime
- 1998-03-04 IL IL13167898A patent/IL131678A0/xx active IP Right Grant
- 1998-03-04 WO PCT/US1998/004135 patent/WO1998039028A1/en active IP Right Grant
- 1998-03-04 PL PL335731A patent/PL190989B1/pl unknown
- 1998-03-04 CA CA002283420A patent/CA2283420C/en not_active Expired - Lifetime
- 1998-03-04 DE DE69839640T patent/DE69839640D1/de not_active Expired - Lifetime
- 1998-03-04 CN CN98804390A patent/CN1252730A/zh active Pending
- 1998-03-04 DK DK98908885T patent/DK0988051T3/da active
- 1998-03-04 AU AU66807/98A patent/AU746185B2/en not_active Expired
- 1998-03-04 ES ES98908885T patent/ES2310004T3/es not_active Expired - Lifetime
- 1998-03-04 BR BR9808821-1A patent/BR9808821A/pt not_active Application Discontinuation
- 1998-03-04 PT PT98908885T patent/PT988051E/pt unknown
- 1998-03-04 JP JP53869998A patent/JP4301415B2/ja not_active Expired - Lifetime
- 1998-03-04 HU HU0001401A patent/HU228709B1/hu unknown
- 1998-03-04 AT AT98908885T patent/ATE399021T1/de active
-
1999
- 1999-09-01 IL IL131678A patent/IL131678A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2310004T3 (es) | 2008-12-16 |
| CA2283420C (en) | 2008-07-22 |
| HUP0001401A3 (en) | 2005-10-28 |
| AU746185B2 (en) | 2002-04-18 |
| HUP0001401A2 (en) | 2000-07-28 |
| JP4301415B2 (ja) | 2009-07-22 |
| DE69839640D1 (de) | 2008-08-07 |
| CA2283420A1 (en) | 1998-09-11 |
| DK0988051T3 (da) | 2008-10-13 |
| AU6680798A (en) | 1998-09-22 |
| CN1252730A (zh) | 2000-05-10 |
| EP0988051B1 (de) | 2008-06-25 |
| PT988051E (pt) | 2008-08-13 |
| US6368603B1 (en) | 2002-04-09 |
| EP0988051A1 (de) | 2000-03-29 |
| IL131678A (en) | 2006-12-31 |
| JP2001513112A (ja) | 2001-08-28 |
| WO1998039028A1 (en) | 1998-09-11 |
| HU228709B1 (en) | 2013-05-28 |
| PL335731A1 (en) | 2000-05-08 |
| IL131678A0 (en) | 2001-03-19 |
| BR9808821A (pt) | 2000-10-24 |
| PL190989B1 (pl) | 2006-02-28 |
| EP0988051A4 (de) | 2004-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE399021T1 (de) | Kombinationszusammensetzungen für die lyme- erkrankung und anwendungen | |
| BR9508985A (pt) | Ligantes de receptores x de ácido retinóico | |
| ATE398676T2 (de) | Antagonistische selektive bindungsagenzien des osteoprotegerin-bindungsproteins | |
| BR0314095A (pt) | Catalisador para a produção de olefinas leves | |
| ATE438638T1 (de) | Sulfoniumsalze als photoinitiatoren für strahlungshärtbare systeme | |
| WO2005035441A3 (en) | Subtituted fullerene compositions and their use as antioxydants | |
| DE69523912D1 (de) | Flubendazole-kautabletten für haustiere | |
| DK0765343T3 (da) | Monoklonale antistoffer imod CD44v6 | |
| UY28912A1 (es) | Procedimiento para la preparación de derivados de 1,4-difenilazetidinona | |
| ATE210078T1 (de) | Hybride kieselsäure-zeolith zusammensetzung | |
| DE50112757D1 (de) | Schwingungsdämpfer für eine hydraulische fahrzeug-bremsanlage | |
| BRPI0417167A (pt) | composições para animais de estimação compreendendo oligofrutose de cadeia curta | |
| ID24903A (id) | Komposisi-komposisi, kit, dan metode untuk menghambat gangguan neurovaskular serebral dan sakit kepala muskular | |
| RU2009120894A (ru) | Вакцина против лаймской болезни собак | |
| BR0210493A (pt) | Composição, e, método para remover cerume humano | |
| ES2093286T3 (es) | Bencimidazoles, medicamentos que contienen estos compuestos y procedimiento para su preparacion. | |
| ATE437780T1 (de) | Verlustleistungsmanagementsystem | |
| BR0017102A (pt) | Agente de liberação, e, método para formar materiais lignocelulósicos ligados com aglutinante de poliisocianato orgânico | |
| DE59809344D1 (de) | Disubstituierte biphenyloxazoline | |
| ATE309412T1 (de) | Träger für spurgebundene fahrzeuge | |
| BR0112185A (pt) | Método para preparar pantotenato de cálcio | |
| BR0309008A (pt) | polipeptìdeos de micoplasma | |
| BR0302267C1 (pt) | dispositivo de castração aplicado em tronco para uso comum | |
| DE50115198D1 (de) | Antihelmintika zur verhinderung von parasitären infektionen bei mensch und tier | |
| IT1297961B1 (it) | Rotaia ibrida e suoi componenti. per ferrovia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0988051 Country of ref document: EP |